Ozempic and Mounjaro Aren’t the Same. Here’s How Weight-Loss Drugs Compare
Scientific American,
New drugs that spur weight loss and treat diabetes have been taking the publicand the pharmaceutical industryby storm.
First-Line Therapy in T2D: Has Metformin Been 'Dethroned'?
Medscape,
Initially approved by the US Food and Drug Administration (FDA) in 1994, metformin has been the preferred first-line glucose-lowe…
Use of Newer Type 2 Diabetes Drugs Gives Hope but Costs a Concern
Medscape,
There is a trend toward greater use of newer glucose-lowering drugs with cardiovascular benefit, raising hopes for better…
Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER
Doc Wire News,
BMC Endocr Disord. 2022 Apr 26;22(1):111. doi: 10.1186/s12902-022-01026-2. ABSTRACT BACKGROUND: Despite strong evidence of…